Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5962946 | International Journal of Cardiology | 2016 | 5 Pages |
ObjectivesWe hypothesized that deceleration capacity (DC), a novel marker of cardiac autonomic modulation, is an independent predictor for mortality in patients with non-ischemic dilated cardiomyopathy (NICM).BackgroundNICM is associated with a high risk for sudden cardiac death (SCD). However there are no clinically established parameters available for risk stratification beyond LVEF.DC has been previously shown to be a strong independent predictor for total mortality in patients after myocardial infarction.MethodsHolter-ECG recordings of 201 patients NICM (83.1% male, mean age: 61.4 years, mean LVEF: 33.3%) were analyzed by the method of phase-rectified-signal-averaging (PRSA) to obtain DC.ResultsDuring a minimum follow-up of 40 month 59 patients died. Kaplan Meyer Analysis showed a significantly higher mortality in patients with a DC below 4.5 ms (log rank p = 0.012) irrespective to the presence of atrial fibrillation.ConclusionsImpaired DC is a powerful independent predictor for mortality in patients with NICM.